CYCLOPHARM LIMITED - Announcements

Market Cap $162.9M Add to my watchlist

Healthcare Medical Devices

Cyclopharm Limited is an Australia-based health technology company. The Company’s... Cyclopharm Limited is an Australia-based health technology company. The Company’s principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. Its subsidiaries include Cyclomedica Europe Limited, Cyclomedica Australia Pty Limited and Cyclomedica Canada Limited.More

Announcements

Filter Results

All Price Sensitive Only

CYC	Cyclopharm Business Update	PRICE SENSITIVE	08:26	190.25KB	Share
CYC	Becoming a substantial holder		26/04/24	91.63KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		26/04/24	494.48KB	Share
CYC	Ceasing to be a substantial holder		24/04/24	213.64KB	Share
CYC	Application for quotation of securities - CYC		08/04/24	17.28KB	Share
CYC	Appendix 4G		26/03/24	510.69KB	Share
CYC	Annual Report to shareholders		26/03/24	3.43MB	Share
CYC	Voluntary Escrow Shares to be Released		25/03/24	77.22KB	Share
CYC	Date of Annual General Meeting		25/03/24	91.17KB	Share
CYC	First USA Patients Imaged with Technegas	PRICE SENSITIVE	19/03/24	146.37KB	Share
CYC	S&P DJI Announces March 2024 Quarterly Rebalance	PRICE SENSITIVE	01/03/24	120.24KB	Share
CYC	CYC Results Summary		28/02/24	182.5KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	28/02/24	613.79KB	Share
CYC	Initial Director's Interest Notice		19/02/24	152KB	Share
CYC	CYC Board Changes		19/02/24	187.9KB	Share
CYC	Cyclopharm Appoints Jason Smith as CFO		12/02/24	116.04KB	Share
CYC	Cyclopharm to Present at Euroz Hartleys Healthcare Forum	PRICE SENSITIVE	06/02/24	3.66MB	Share
CYC	Cyclopharm Trading and USA Launch Update	PRICE SENSITIVE	05/02/24	137.46KB	Share
CYC	CYC and Yale Translational Research Partner on Technegas		29/01/24	119.27KB	Share
CYC	Cyclopharm Signs First USA Contract for Technegas	PRICE SENSITIVE	05/12/23	130.72KB	Share
CYC	Change of Director's Interest Notice		01/12/23	191.29KB	Share
CYC	Application for quotation of securities - CYC		01/12/23	24.85KB	Share
CYC	Technegas USA Commercialisation Update		15/11/23	149.47KB	Share
CYC	Change of Director's Interest Notice		02/11/23	212.22KB	Share
CYC	Change of Director's Interest Notice		01/11/23	211.04KB	Share
CYC	CYC USFDA Approval Webinar Presentation		05/10/23	2.76MB	Share
CYC	FDA Technegas Approval Webinar		03/10/23	121.12KB	Share
CYC	SNMMI Announcement Regarding USFDA Approval of Technegas		03/10/23	171.81KB	Share
CYC	Cyclopharm Receives USFDA Approval for Technegas	PRICE SENSITIVE	02/10/23	169.57KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	146.19KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	3.07MB	Share
CYC	Cyclopharm Investor Update	PRICE SENSITIVE	26/09/23	3.01MB	Share
CYC	Application for quotation of securities - CYC		12/09/23	26.13KB	Share
CYC	Litigation Update and Receipt of Settlement Payment	PRICE SENSITIVE	25/08/23	149.34KB	Share
CYC	Dividend/Distribution - CYC		22/08/23	22.19KB	Share
CYC	Half Year Accounts	PRICE SENSITIVE	22/08/23	704.25KB	Share
CYC	USFDA Approval Process Update	PRICE SENSITIVE	09/08/23	175.08KB	Share
CYC	Cyclopharm 2023 Half Year Accounts Update - Record Revenues	PRICE SENSITIVE	17/07/23	146.72KB	Share
CYC	Notification of buy-back - CYC	PRICE SENSITIVE	16/05/23	21.97KB	Share
CYC	Results of Meeting		16/05/23	136.56KB	Share
CYC	Managing Director's Address to Shareholders		16/05/23	257.01KB	Share
CYC	CYC 2023 AGM Presentation		16/05/23	2.11MB	Share
CYC	Chairman's Address to Shareholders		16/05/23	148.18KB	Share
CYC	Cyclopharm Confirms USFDA Scheduled Inspection Date	PRICE SENSITIVE	09/05/23	174.75KB	Share
CYC	USFDA Confirms Technegas Six Month Review Period	PRICE SENSITIVE	24/04/23	176.33KB	Share
CYC	Cyclopharm Acquires DuPharma ApS		20/04/23	157.4KB	Share
CYC	Application for quotation of securities - CYC		18/04/23	24.73KB	Share
CYC	Proposed issue of securities - CYC		17/04/23	25.38KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		13/04/23	1.24MB	Share
CYC	Cyclopharm USFDA Approval Progress Update		05/04/23	3.63MB	Share
CYC	Appendix 4G		31/03/23	427.76KB	Share
CYC	Annual Report to shareholders		31/03/23	5.14MB	Share
CYC	Technegas Enters Final Six Month USFDA Review Cycle	PRICE SENSITIVE	30/03/23	201.56KB	Share
CYC	Application for quotation of securities - CYC		24/03/23	26.47KB	Share
CYC	Date of Annual General Meeting		15/03/23	74.84KB	Share
CYC	CYC Results Summary		20/02/23	161.69KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	20/02/23	514.93KB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	20/02/23	22.36KB	Share
CYC	Change of Director's Interest Notice - KBarrow		05/12/22	200.56KB	Share
CYC	Change of Director's Interest Notice - DAngus		30/11/22	200.24KB	Share
CYC	Cyclopharm Receives $1.64m R&D Refund	PRICE SENSITIVE	29/11/22	139.2KB	Share
CYC	Bell Potter Healthcare Conference Directors Profile		09/11/22	2.58MB	Share
CYC	Bell Potter Healthcare Conference		09/11/22	2.57MB	Share
CYC	Notification of cessation of securities - CYC		05/10/22	21.48KB	Share
CYC	CYC Board Changes		27/09/22	155.81KB	Share
CYC	Initial Director's Interest Notice		27/09/22	119.11KB	Share
CYC	Initial Director's Interest Notice		01/09/22	119.43KB	Share
CYC	CYC Board Changes		01/09/22	153.49KB	Share
CYC	Half Year 2022 Results	PRICE SENSITIVE	17/08/22	278.97KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	17/08/22	1.43MB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	17/08/22	22.2KB	Share
CYC	Technegas Used In Multicenter COVID Study	PRICE SENSITIVE	07/07/22	176.04KB	Share
CYC	1H 2022 Business Update - Record Revenues	PRICE SENSITIVE	04/07/22	170.6KB	Share
CYC	Change of Director's Interest Notice		14/06/22	200.41KB	Share
CYC	CYC Investor Presentation 24 May 2022		24/05/22	5.5MB	Share
CYC	Technegas used in Diagnosing Long COVID		24/05/22	207.5KB	Share
CYC	Change of Director's Interest Notice		23/05/22	200.4KB	Share
CYC	Results of Meeting		17/05/22	136.84KB	Share
CYC	Managing Director's Address to Shareholders		17/05/22	230.34KB	Share
CYC	CYC 2022 AGM Presentation		17/05/22	2.46MB	Share
CYC	Chairman's Address to Shareholders		17/05/22	202.55KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		14/04/22	933.11KB	Share
CYC	Appendix 4G		31/03/22	379.93KB	Share
CYC	Annual Report to shareholders		31/03/22	1.69MB	Share
CYC	Date of Annual General Meeting		16/03/22	74.85KB	Share
CYC	Change of Director's Interest Notice		09/03/22	199.91KB	Share
CYC	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
CYC	CYC Results Summary	PRICE SENSITIVE	23/02/22	153.79KB	Share
CYC	Dividend/Distribution - CYC		23/02/22	22.36KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	23/02/22	496.91KB	Share
CYC	Cyclopharm USFDA Update	PRICE SENSITIVE	03/02/22	125.83KB	Share
CYC	Cyclopharm Business Update	PRICE SENSITIVE	24/01/22	175.05KB	Share
CYC	Final Director's Interest Notice		01/12/21	156.73KB	Share
CYC	Board Update		01/12/21	112.15KB	Share
CYC	Bell Potter HealthCare Conference		09/11/21	7.02MB	Share
CYC	Jobkeeper Payments Notice		28/10/21	148.47KB	Share
CYC	Half Year 2021 Financial Results	PRICE SENSITIVE	23/08/21	169.33KB	Share
CYC	Dividend/Distribution - CYC		23/08/21	22.19KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/08/21	1.72MB	Share
CYC	Initial Director's Interest Notice		10/08/21	150.29KB	Share

CYC Cyclopharm Business Update
08:26	PRICE SENSITIVE	190.25KB	Share
CYC Becoming a substantial holder
26/04/24		91.63KB	Share
CYC Notice of Annual General Meeting/Proxy Form
26/04/24		494.48KB	Share
CYC Ceasing to be a substantial holder
24/04/24		213.64KB	Share
CYC Application for quotation of securities - CYC
08/04/24		17.28KB	Share
CYC Appendix 4G
26/03/24		510.69KB	Share
CYC Annual Report to shareholders
26/03/24		3.43MB	Share
CYC Voluntary Escrow Shares to be Released
25/03/24		77.22KB	Share
CYC Date of Annual General Meeting
25/03/24		91.17KB	Share
CYC First USA Patients Imaged with Technegas
19/03/24	PRICE SENSITIVE	146.37KB	Share
CYC S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24	PRICE SENSITIVE	120.24KB	Share
CYC CYC Results Summary
28/02/24		182.5KB	Share
CYC Preliminary Final Report
28/02/24	PRICE SENSITIVE	613.79KB	Share
CYC Initial Director's Interest Notice
19/02/24		152KB	Share
CYC CYC Board Changes
19/02/24		187.9KB	Share
CYC Cyclopharm Appoints Jason Smith as CFO
12/02/24		116.04KB	Share
CYC Cyclopharm to Present at Euroz Hartleys Healthcare Forum
06/02/24	PRICE SENSITIVE	3.66MB	Share
CYC Cyclopharm Trading and USA Launch Update
05/02/24	PRICE SENSITIVE	137.46KB	Share
CYC CYC and Yale Translational Research Partner on Technegas
29/01/24		119.27KB	Share
CYC Cyclopharm Signs First USA Contract for Technegas
05/12/23	PRICE SENSITIVE	130.72KB	Share
CYC Change of Director's Interest Notice
01/12/23		191.29KB	Share
CYC Application for quotation of securities - CYC
01/12/23		24.85KB	Share
CYC Technegas USA Commercialisation Update
15/11/23		149.47KB	Share
CYC Change of Director's Interest Notice
02/11/23		212.22KB	Share
CYC Change of Director's Interest Notice
01/11/23		211.04KB	Share
CYC CYC USFDA Approval Webinar Presentation
05/10/23		2.76MB	Share
CYC FDA Technegas Approval Webinar
03/10/23		121.12KB	Share
CYC SNMMI Announcement Regarding USFDA Approval of Technegas
03/10/23		171.81KB	Share
CYC Cyclopharm Receives USFDA Approval for Technegas
02/10/23	PRICE SENSITIVE	169.57KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	146.19KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	3.07MB	Share
CYC Cyclopharm Investor Update
26/09/23	PRICE SENSITIVE	3.01MB	Share
CYC Application for quotation of securities - CYC
12/09/23		26.13KB	Share
CYC Litigation Update and Receipt of Settlement Payment
25/08/23	PRICE SENSITIVE	149.34KB	Share
CYC Dividend/Distribution - CYC
22/08/23		22.19KB	Share
CYC Half Year Accounts
22/08/23	PRICE SENSITIVE	704.25KB	Share
CYC USFDA Approval Process Update
09/08/23	PRICE SENSITIVE	175.08KB	Share
CYC Cyclopharm 2023 Half Year Accounts Update - Record Revenues
17/07/23	PRICE SENSITIVE	146.72KB	Share
CYC Notification of buy-back - CYC
16/05/23	PRICE SENSITIVE	21.97KB	Share
CYC Results of Meeting
16/05/23		136.56KB	Share
CYC Managing Director's Address to Shareholders
16/05/23		257.01KB	Share
CYC CYC 2023 AGM Presentation
16/05/23		2.11MB	Share
CYC Chairman's Address to Shareholders
16/05/23		148.18KB	Share
CYC Cyclopharm Confirms USFDA Scheduled Inspection Date
09/05/23	PRICE SENSITIVE	174.75KB	Share
CYC USFDA Confirms Technegas Six Month Review Period
24/04/23	PRICE SENSITIVE	176.33KB	Share
CYC Cyclopharm Acquires DuPharma ApS
20/04/23		157.4KB	Share
CYC Application for quotation of securities - CYC
18/04/23		24.73KB	Share
CYC Proposed issue of securities - CYC
17/04/23		25.38KB	Share
CYC Notice of Annual General Meeting/Proxy Form
13/04/23		1.24MB	Share
CYC Cyclopharm USFDA Approval Progress Update
05/04/23		3.63MB	Share
CYC Appendix 4G
31/03/23		427.76KB	Share
CYC Annual Report to shareholders
31/03/23		5.14MB	Share
CYC Technegas Enters Final Six Month USFDA Review Cycle
30/03/23	PRICE SENSITIVE	201.56KB	Share
CYC Application for quotation of securities - CYC
24/03/23		26.47KB	Share
CYC Date of Annual General Meeting
15/03/23		74.84KB	Share
CYC CYC Results Summary
20/02/23		161.69KB	Share
CYC Preliminary Final Report
20/02/23	PRICE SENSITIVE	514.93KB	Share
CYC Dividend/Distribution - CYC
20/02/23	PRICE SENSITIVE	22.36KB	Share
CYC Change of Director's Interest Notice - KBarrow
05/12/22		200.56KB	Share
CYC Change of Director's Interest Notice - DAngus
30/11/22		200.24KB	Share
CYC Cyclopharm Receives $1.64m R&D Refund
29/11/22	PRICE SENSITIVE	139.2KB	Share
CYC Bell Potter Healthcare Conference Directors Profile
09/11/22		2.58MB	Share
CYC Bell Potter Healthcare Conference
09/11/22		2.57MB	Share
CYC Notification of cessation of securities - CYC
05/10/22		21.48KB	Share
CYC CYC Board Changes
27/09/22		155.81KB	Share
CYC Initial Director's Interest Notice
27/09/22		119.11KB	Share
CYC Initial Director's Interest Notice
01/09/22		119.43KB	Share
CYC CYC Board Changes
01/09/22		153.49KB	Share
CYC Half Year 2022 Results
17/08/22	PRICE SENSITIVE	278.97KB	Share
CYC Half Yearly Report and Accounts
17/08/22	PRICE SENSITIVE	1.43MB	Share
CYC Dividend/Distribution - CYC
17/08/22	PRICE SENSITIVE	22.2KB	Share
CYC Technegas Used In Multicenter COVID Study
07/07/22	PRICE SENSITIVE	176.04KB	Share
CYC 1H 2022 Business Update - Record Revenues
04/07/22	PRICE SENSITIVE	170.6KB	Share
CYC Change of Director's Interest Notice
14/06/22		200.41KB	Share
CYC CYC Investor Presentation 24 May 2022
24/05/22		5.5MB	Share
CYC Technegas used in Diagnosing Long COVID
24/05/22		207.5KB	Share
CYC Change of Director's Interest Notice
23/05/22		200.4KB	Share
CYC Results of Meeting
17/05/22		136.84KB	Share
CYC Managing Director's Address to Shareholders
17/05/22		230.34KB	Share
CYC CYC 2022 AGM Presentation
17/05/22		2.46MB	Share
CYC Chairman's Address to Shareholders
17/05/22		202.55KB	Share
CYC Notice of Annual General Meeting/Proxy Form
14/04/22		933.11KB	Share
CYC Appendix 4G
31/03/22		379.93KB	Share
CYC Annual Report to shareholders
31/03/22		1.69MB	Share
CYC Date of Annual General Meeting
16/03/22		74.85KB	Share
CYC Change of Director's Interest Notice
09/03/22		199.91KB	Share
CYC S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
CYC CYC Results Summary
23/02/22	PRICE SENSITIVE	153.79KB	Share
CYC Dividend/Distribution - CYC
23/02/22		22.36KB	Share
CYC Preliminary Final Report
23/02/22	PRICE SENSITIVE	496.91KB	Share
CYC Cyclopharm USFDA Update
03/02/22	PRICE SENSITIVE	125.83KB	Share
CYC Cyclopharm Business Update
24/01/22	PRICE SENSITIVE	175.05KB	Share
CYC Final Director's Interest Notice
01/12/21		156.73KB	Share
CYC Board Update
01/12/21		112.15KB	Share
CYC Bell Potter HealthCare Conference
09/11/21		7.02MB	Share
CYC Jobkeeper Payments Notice
28/10/21		148.47KB	Share
CYC Half Year 2021 Financial Results
23/08/21	PRICE SENSITIVE	169.33KB	Share
CYC Dividend/Distribution - CYC
23/08/21		22.19KB	Share
CYC Half Yearly Report and Accounts
23/08/21	PRICE SENSITIVE	1.72MB	Share
CYC Initial Director's Interest Notice
10/08/21		150.29KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last $1.73		Change -0.070(3.89%)		Mkt cap ! $162.9M

Open	High	Low	Value	Volume
$1.80	$1.80	$1.73	$57.22K	32.86K

Buyers (Bids)

No.	Vol.	Price($)
2	9499	$1.73

Sellers (Offers)

Price($)	Vol.	No.
$1.80	6189	2

View Market Depth

No.	Vol.	Price($)
2	9499	1.730
2	1462	1.720
1	295	1.700
1	10000	1.660
1	300	1.600

Price($)	Vol.	No.
1.800	6189	2
1.810	2000	1
1.815	1200	1
1.820	4176	2
1.900	537	1

Last trade - 16.10pm 06/05/2024 (20 minute delay)


Last $1.75		Change -0.070 ( 1.69 %)
Open	High	Low	Volume
$1.75	$1.76	$1.75	946
Last updated 13.36pm 06/05/2024 ?

CYC (ASX) Chart

CYCLOPHARM LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories